Synthomer plc

LSE:SYNT Voorraadrapport

Marktkapitalisatie: UK£112.6m

Synthomer Inkomsten in het verleden

Verleden criteriumcontroles 0/6

De winst van Synthomer is gedaald met een gemiddeld jaarlijks percentage van -56.3%, terwijl de winst van de Chemicals -industrie jaarlijks groeide met 3.3%. De inkomsten zijn daalde met een gemiddeld percentage van 2.1% per jaar.

Belangrijke informatie

-56.32%

Groei van de winst

-63.62%

Groei van de winst per aandeel

Chemicals Groei van de industrie4.35%
Inkomstengroei-2.05%
Rendement op eigen vermogen-16.41%
Nettomarge-8.64%
Laatste winstupdate31 Dec 2025

Recente prestatie-updates uit het verleden

Recent updates

SYNT: Cost Actions And Bio-Based Shift Will Support Future Margin Stability

Analysts have slightly reduced their price expectations for Synthomer, reflecting updated assumptions for a less pronounced revenue decline, a small reduction in forecast profit margins, and a modest adjustment to future P/E. Taken together, these changes leave their fair value estimate unchanged at £0.59 per share.

SYNT: Cost Cuts And Bio Based Shift Will Support Future Upside

Analysts have nudged their price target on Synthomer slightly, reflecting modest tweaks to assumptions around discount rate, profit margin and future P/E, while keeping the underlying fair value estimate broadly unchanged at £1.27. What's in the News Godavari Biorefineries Limited entered a partnership with Synthomer to develop bio-based alternatives to existing fossil-based monomers, targeting growing customer demand for lower carbon and more sustainable materials (Key Developments).

SYNT: Cost Actions And Bio-Based Partnership Will Support Future Margin Resilience

Analysts have adjusted their Synthomer price targets slightly to reflect updated views on revenue contraction, slightly higher profit margins, and a modestly lower future P/E, resulting in a revised fair value estimate of £0.59 per share. What's in the News Synthomer entered a partnership with Godavari Biorefineries Limited to develop bio-based alternatives to existing fossil-based monomers.

SYNT: Cost Actions And Bio Based Shift Will Support Earnings Recovery

Analysts have trimmed their price target on Synthomer from £1.34 to about £1.27, citing updated assumptions on revenue growth, profit margins and future P/E multiples as they reassess the balance of risk and reward. What's in the News Godavari Biorefineries Limited partnered with Synthomer to develop bio-based alternatives to existing fossil-based monomers, including commercialisation of bio-based butyl acrylate using bio-based butanol from GBL, aimed at supporting customer demand for lower carbon materials (Key Developments).

SYNT: Cost Actions And Bio-Based Shift Will Support Future Margin Resilience

Analysts have nudged their price target on Synthomer higher to £0.59. This reflects updated assumptions around slightly less severe revenue contraction and broadly unchanged profit margins and P/E expectations.

SYNT: Cost Actions And Margin Resilience Will Support A Stable Fair Value View

Analysts have nudged their fair value estimate for Synthomer to £0.59 from £0.55, citing revised assumptions around revenue growth, profit margins and future P/E as the key drivers of the updated price target. What's in the News Synthomer issued earnings guidance for the twelve months to 31 December 2025, with expected 2025 revenue of around £1.74b compared with £1.93b for 2024, described as in line with market expectations (Key Developments).

SYNT: Earnings Prospects Will Stabilise As Fair Value View Remains Intact

Analysts have adjusted their price targets on Synthomer, reflecting revised assumptions around revenue growth, profit margins and future P/E multiples. Together, these changes point to a recalibrated view of the company’s earnings potential within an unchanged fair value estimate of £0.55 per share.

SYNT: Self Help And 2026 Outlook Will Support Earnings Recovery

Analysts have trimmed their price expectations for Synthomer, with a lower fair value estimate and a reduced Street target to £1.02 from £1.12. This reflects updated views on revenue growth and earnings multiples while maintaining a broadly neutral stance on the shares.

SYNT Will Face Mounting Pressure As Earnings Recovery Outlook Deteriorates

The analyst price target for Synthomer has been reduced to £1.02 per share from £1.12, as analysts factor in slower revenue growth assumptions, despite slightly higher profit margin expectations and a marginally increased discount rate. Analyst Commentary Recent research updates highlight a cautious stance from bearish analysts, who have progressively lowered their price targets on Synthomer as they reassess the company’s growth trajectory and risk profile.

SYNT: Self-Help Actions Will Drive Earnings Recovery Despite Neutral Market Sentiment

Analysts have trimmed their price target on Synthomer slightly. This reflects a modest recalibration in fair value to approximately £1.34 per share following a series of recent target cuts that have reset expectations for the stock.

SYNT: Full-Year Self-Help Actions Will Drive Earnings Recovery Momentum

Analysts have revised their price target for Synthomer downward from GBp 112 to GBp 102. This change is attributed to adjustments to future valuation metrics and an updated earnings outlook.

SYNT: Future Gains Are Expected As End Markets Gradually Stabilize

Synthomer's analyst price target has been reduced from 112 GBp to 102 GBp. Analysts cite persistent end-market challenges and limited near-term prospects for earnings recovery as key factors behind the downward revision. Analyst Commentary Recent analyst coverage reflects a spectrum of perspectives regarding Synthomer's outlook, shaped by evolving market dynamics and the company's updated financial guidance.

Future Earnings And Recovery Prospects Will Remain Under Pressure Amid Market Challenges

Synthomer's fair value estimate has been revised downward from £1.54 to £1.38 per share. Analysts cite ongoing challenges in end markets and modest growth prospects following the company's recent interim results.

UK£1.57: That's What Analysts Think Synthomer plc (LON:SYNT) Is Worth After Its Latest Results

Aug 09
UK£1.57: That's What Analysts Think Synthomer plc (LON:SYNT) Is Worth After Its Latest Results

Sustainable Specialty Polymers Will Unlock New Global Opportunities

Despite a notable upgrade in revenue growth forecasts and a reduction in the forward P/E, Synthomer's consensus analyst price target has been revised down from £1.71 to £1.57. Valuation Changes Summary of Valuation Changes for Synthomer The Consensus Analyst Price Target has fallen from £1.71 to £1.57.
User avatar

Chemical Realignment And Adhesives Expansion Will Build A Resilient Future

Shift to high-margin specialty chemicals and divestment of non-core operations are expected to enhance profitability.

Investors Aren't Entirely Convinced By Synthomer plc's (LON:SYNT) Revenues

Jan 08
Investors Aren't Entirely Convinced By Synthomer plc's (LON:SYNT) Revenues

Synthomer plc (LON:SYNT) Screens Well But There Might Be A Catch

Oct 05
Synthomer plc (LON:SYNT) Screens Well But There Might Be A Catch

Calculating The Intrinsic Value Of Synthomer plc (LON:SYNT)

Aug 03
Calculating The Intrinsic Value Of Synthomer plc (LON:SYNT)

Synthomer (LON:SYNT) Has Debt But No Earnings; Should You Worry?

Jun 18
Synthomer (LON:SYNT) Has Debt But No Earnings; Should You Worry?

Investors Still Aren't Entirely Convinced By Synthomer plc's (LON:SYNT) Revenues Despite 27% Price Jump

May 25
Investors Still Aren't Entirely Convinced By Synthomer plc's (LON:SYNT) Revenues Despite 27% Price Jump

Is Synthomer plc (LON:SYNT) Expensive For A Reason? A Look At Its Intrinsic Value

Apr 20
Is Synthomer plc (LON:SYNT) Expensive For A Reason? A Look At Its Intrinsic Value

Even With A 45% Surge, Cautious Investors Are Not Rewarding Synthomer plc's (LON:SYNT) Performance Completely

Mar 14
Even With A 45% Surge, Cautious Investors Are Not Rewarding Synthomer plc's (LON:SYNT) Performance Completely

Should You Think About Buying Synthomer plc (LON:SYNT) Now?

Feb 08
Should You Think About Buying Synthomer plc (LON:SYNT) Now?

Is Now An Opportune Moment To Examine Synthomer plc (LON:SYNT)?

Oct 17
Is Now An Opportune Moment To Examine Synthomer plc (LON:SYNT)?

Here's Why Synthomer (LON:SYNT) Is Weighed Down By Its Debt Load

Sep 12
Here's Why Synthomer (LON:SYNT) Is Weighed Down By Its Debt Load

Opbrengsten en kosten

Hoe Synthomer geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

LSE:SYNT Opbrengsten, kosten en inkomsten (GBP Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
31 Dec 251,739-15050
30 Sep 251,826-1131010
30 Jun 251,886-761980
31 Mar 251,937-731990
31 Dec 241,987-701990
30 Sep 241,940-781830
30 Jun 241,919-861670
31 Mar 241,930-961670
31 Dec 231,941-1051670
30 Sep 232,046-1271650
30 Jun 232,151-1491630
31 Mar 232,242-841630
31 Dec 222,332-181630
30 Jun 222,143801710
31 Mar 222,1431391710
31 Dec 212,1441981720
30 Sep 212,2352131870
30 Jun 212,1412171830
31 Mar 211,8921101830
31 Dec 201,64431830
30 Sep 201,537141410
30 Jun 201,430241000
31 Mar 201,445541000
31 Dec 191,459851000
30 Sep 191,503811080
30 Jun 191,548771160
31 Mar 191,583891160
31 Dec 181,6191001160
30 Sep 181,5811011150
30 Jun 181,5441021130
31 Mar 181,512881140
31 Dec 171,480741140
30 Sep 171,425901060
30 Jun 171,370105990
31 Mar 171,208108990
31 Dec 161,046110990
30 Sep 1695495880
30 Jun 1686279770
31 Mar 1686670760
31 Dec 1587060760
30 Sep 1589256660
30 Jun 1591351560

Kwaliteitswinsten: SYNT is momenteel verliesgevend.

Groeiende winstmarge: SYNT is momenteel verliesgevend.

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: SYNT is verliesgevend en de verliezen zijn de afgelopen 5 jaar toegenomen met een snelheid van 56.3% per jaar.

Versnelling van de groei: Het is niet mogelijk om de winstgroei van SYNT over het afgelopen jaar te vergelijken met het gemiddelde over de afgelopen vijf jaar, omdat het bedrijf momenteel verliesgevend is.

Winst versus industrie: SYNT is verlieslatend, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Chemicals industrie ( -16.6% ).

Rendement op eigen vermogen

Hoge ROE: SYNT heeft een negatief Return on Equity ( -16.41% ), omdat het momenteel verliesgevend is.

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden

7D

1Y

7D

1Y

7D

1Y

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/05/01 18:07
Aandelenkoers aan het einde van de dag2026/05/01 00:00
Inkomsten2025/12/31
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Synthomer plc wordt gevolgd door 21 analisten. 7 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Katie RichardsBarclays
Robert BateBarclays
James StewartBarclays